• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » NuVasive co-founder McKinley is Vascular Dynamics new COO | Personnel Moves June 9, 2016 » Page 3

NuVasive co-founder McKinley is Vascular Dynamics new COO | Personnel Moves June 9, 2016

June 9, 2016 By Fink Densford

ViewRay taps Bansal as new CFO


viewray-bansal

ViewRay said today it appointed ex-Onconova Therapeutics exec Ajay Bansal as its new chief financial officer, succeeding former CFO David Chandler.

“I am delighted to welcome Ajay to ViewRay. We are at an exciting stage in our Company’s development, as we remain on track to complete our regulatory submissions for our MRIdian linac technology in the second half of 2016 and prepare to commercialize this important innovation. Ajay’s deep experience makes him the ideal person to help us manage our growth and build shareholder value. I would like to thank David Chandler for his 6 years with ViewRay, which culminated in our company’s recent listing on the NASDAQ Global Market, and for his willingness to continue commuting from Seattle until we could find a top quality successor,” CEO Chris Raanes said in a press release.

Read more

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8

Filed Under: Business/Financial News Tagged With: Advent Medical, Endosphere, Getinge, Haemonetics, InVivo Therapeutics, Nellix Inc., Nuvasive, Prism Medical, vasculardynamics, ViewRay Inc., Westwicke Partners, Zynex Inc.

More recent news

  • AiM Medical Robotics’ $2M NIH grant and other extra medtech news
  • Intuitive draws on data from 14M cases to back da Vinci systems
  • Ropca wins FDA clearance for ultrasound automation systems
  • Zimmer Biomet lets go of former Nevro CEO amid leadership restructuring
  • Petal Surgical says its first-in-human incisionless surgery is coming soon and offers a first glimpse of its system

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy